Raymond James Financial Services Advisors Inc. Has $38.69 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Raymond James Financial Services Advisors Inc. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 120,436 shares of the company’s stock after buying an additional 255 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in HCA Healthcare were worth $38,694,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bangor Savings Bank grew its stake in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC grew its stake in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Atlantic Edge Private Wealth Management LLC purchased a new position in HCA Healthcare in the fourth quarter valued at about $27,000. LifeSteps Financial Inc. bought a new stake in shares of HCA Healthcare during the 1st quarter worth about $33,000. Finally, Northwest Investment Counselors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter worth about $36,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on HCA. Deutsche Bank Aktiengesellschaft upped their price target on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. TD Cowen cut their price objective on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Truist Financial upped their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday. Finally, Royal Bank of Canada upped their price target on HCA Healthcare from $329.00 to $378.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Four equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $354.67.

HCA Healthcare Price Performance

NYSE HCA traded up $0.15 during trading hours on Monday, reaching $373.92. 515,446 shares of the company’s stock were exchanged, compared to its average volume of 1,144,494. The stock has a market cap of $97.93 billion, a PE ratio of 18.64, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm has a fifty day moving average of $341.10 and a 200-day moving average of $329.01. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $375.81.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period last year, the company earned $4.29 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.71%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insider Buying and Selling

In related news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,844 shares of company stock valued at $3,185,932. 1.60% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.